English
Regional settings| Spread | 0.05 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 4.24 |
| Open | 4.21 |
| 1-Year Change | -71.52% |
| Day's Range | 4.04 - 4.23 |
PetMed Express, Inc. is a pet pharmacy. The Company markets prescription and non-prescription pet medications, health products and supplies for dogs, cats and horses, direct to the consumer. The Company’s product line contains approximately 3,000 stock-keeping units (SKUs). It also offers sale additional pet supplies on its Website, which are drop shipped to the customers by third parties. Its product line provides customers with a range of selections across the health categories for dogs, cats and horses. The Company’s current products include Non-Prescription Medications (OTC) and supplies and Prescription Medications (Rx). OTC includes flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes Heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
BRIEF: For the nine months ended 31 December 2021, Petmed Express Inc revenues decreased 13% to $207.4M. Net income decreased 37% to $15M. Revenues reflect Internet Sales segment decrease of 13% to $173.7M, Sales - Internet sales decrease of 9% to $189.3M. Net income also reflects Merchandise Margins, Total -% decrease of 2% to 29.2%, General and Administrative increase of 7% to $22.5M (expense).
Common Stock $.001 Par, 01/11, 40M auth., 22,521,433 issd., Insiders & Stakeholder owns 3.47%. Preferred Stock $.001Par, 5M auth., 3,000 issd. IPO: NA.
